Immunoregulatory effects of freeze injured whole tumour cells on human dendritic cells using an in vitro cryotherapy model

Cryobiology

Volumn 61, Issue 3, 2010, Pages 268-274

  Ismail, Mohamed ^a   Morgan, Richard ^a   Harrington, Kevin ^b   Davies, John ^c   Pandha, Hardev ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Cryotherapy; Cytokine; Dendritic cells

Indexed keywords

B7 ANTIGEN; CASPASE 8; CD83 ANTIGEN; CD86 ANTIGEN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL DAMAGE; CELL FUNCTION; CELL MATURATION; COCULTURE; COLD INJURY; CONTROLLED STUDY; CRYOTHERAPY; DENDRITIC CELL; FREEZING; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; MALE; MICROARRAY ANALYSIS; MIXED LYMPHOCYTE REACTION; MONOCYTE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; STORAGE TEMPERATURE; THERAPY EFFECT;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CELL LINE, TUMOR; CRYOTHERAPY; DENDRITIC CELLS; FREEZING; GENE EXPRESSION PROFILING; HUMANS; IMMUNOGLOBULINS; INTERLEUKINS; MALE; MEMBRANE GLYCOPROTEINS; PROSTATIC NEOPLASMS; UP-REGULATION;

EID: 78649644393     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2010.09.004     Document Type: Article

References (29)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
2. Bayjoo P., Rees R.C., Goepel J.R., Jacob G. Natural killer cell activity following cryosurgery of normal and tumour bearing liver in an animal model. J. Clin. Lab. Immunol. 1991, 35:129-132.
3. Burch P.A., Breen J.K., Buckner J.C., Gastineau D.A., Kaur J.A., Laus R.L., Padley D.J., Peshwa M.V., Pitot H.C., Richardson R.L., Smits B.J., Sopapan P., Strang G., Valone F.H., Vuk-Pavlovic S. Priming tissue-specific cellular immunity in a Phase I trial of autologous dendritic cells for prostate cancer. Clin. Cancer Res. 2000, 6:2175-2182.
4. den Brok M.H., Sutmuller R.P., van der Voort R., Bennink E.J., Figdor C.G., Ruers T.J., Adema G.J. In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res. 2004, 64:4024-4029.
5. den Brok M.H., Sutmuller R.P., Nierkens S., Bennink E.J., Frielink C., Toonen L.W., Boerman O.C., Figdor C.G., Ruers T.J., Adema G.J. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br. J. Cancer 2006, 95:896-905.
6. Friedman E.J., Orth C.R., Brewton K.A., Ponniah S., Alexander R.B. Cryosurgical ablation of the normal ventral prostate plus adjuvant does not protect Copenhagen rats from Dunning prostatic adenocarcinoma challenge. J. Urol. 1997, 158:1585-1588.
7. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 1999, 5:1249-1255.
8. Hernandez-Lopez C., Valencia J., Hidalgo L., Martinez V.G., Zapata A.G., Sacedon R., Varas A., Vicente A. CXCL12/CXCR4 signaling promotes human thymic dendritic cell survival regulating the Bcl-2/Bax ratio. Immunol. Lett. 2008, 120:72-78.
9. Higano C.S., Schellhammer P.F., Small E.J., Burch P.A., Nemunaitis J., Yuh L., Provost N., Frohlich M.W. Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer. Cancer 2009, 115:3670-3679.
10. Hoffmann N.E., Coad J.E., Huot C.S., Swanlund D.J., Bischof J.C. Investigation of the mechanism and the effect of cryoimmunology in the Copenhagen rat. Cryobiology 2001, 42:59-68.
11. Ismail M., Pandha H., Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: current status and future perspectives. Therapy 2008, 5:37-45.
12. Ismail M., Morgan R., Harrington K., Davies J., Pandha H. Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model. Cryobiology 2009, 59:207-213.
13. Joosten J.J., Muijen G.N., Wobbes T., Ruers T.J. In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study. Cryobiology 2001, 42:49-58.
14. Kramer J.L., Baltathakis I., Alcantara O.S., Boldt D.H. Differentiation of functional dendritic cells and macrophages from human peripheral blood monocyte precursors is dependent on expression of p21 (WAF1/CIP1) and requires iron. Br. J. Haematol. 2002, 117:727-734.
15. Machlenkin A., Goldberger O., Tirosh B., Paz A., Volovitz I., Bar-Haim E., Lee S.H., Vadai E., Tzehoval E., Eisenbach L. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity. Clin. Cancer Res. 2005, 11:4955-4961.
16. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994, 12:991-1045.
17. Pandha H.S., John R.J., Hutchinson J., James N., Whelan M., Corbishley C., Dalgleish A.G. Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study. BJU Int. 2004, 94:412-418.
18. Reid S.D., Penna G., Adorini L. The control of T cell responses by dendritic cell subsets. Curr. Opin. Immunol. 2000, 12:114-121.
19. Sabel M.S. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology 2009, 58:1-11.
20. Sabel M.S., Nehs M.A., Su G., Lowler K.P., Ferrara J.L., Chang A.E. Immunologic response to cryoablation of breast cancer. Breast Cancer Res. Treat. 2005, 90:97-104.
21. Salio M., Cerundolo V., Lanzavecchia A. Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells. Eur. J. Immunol. 2000, 30:705-708.
22. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000, 191:423-434.
23. Schoppet M., Henser S., Ruppert V., Stubig T., Al Fakhri N., Maisch B., Hofbauer L.C. Osteoprotegerin expression in dendritic cells increases with maturation and is NF-κB-dependent. J. Cell Biochem. 2007, 100:1430-1439.
24. Soanes W.A., Ablin R.J., Gonder M.J. Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J. Urol. 1970, 104:154-159.
25. Steinman R.M., Mellman I. Immunotherapy: bewitched, bothered, and bewildered no more. Science 2004, 305:197-200.
26. Strome S.E., Voss S., Wilcox R., Wakefield T.L., Tamada K., Flies D., Chapoval A., Lu J., Kasperbauer J.L., Padley D., Vile R., Gastineau D., Wettstein P., Chen L. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res. 2002, 62:1884-1889.
27. Todryk S.M., Eaton J., Birchall L., Greenhalgh R., Soars D., Dalgleish A.G., Melcher A.A., Pandha H.S. Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity. Cancer Immunol. Immunother. 2004, 53:323-330.
28. Udagawa M., Kudo-Saito C., Hasegawa G., Yano K., Yamamoto A., Yaguchi M., Toda M., Azuma I., Iwai T., Kawakami Y. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation. Clin. Cancer Res. 2006, 12:7465-7475.
29. Yantorno C., Soanes W.A., Gonder M.J., Shulman S. Studies in cryo-immunology. I. The production of antibodies to urogenital tissue in consequence of freezing treatment. Immunology 1967, 12:395-410.